Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly Godbout

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Cells|February 25, 2023
Prime Editing for Human Gene Therapy: Where Are We Now?Kelly Godbout, Jacques P Tremblay
Pharmaceutics|October 27, 2022
Delivery of RNAs to Specific Organs by Lipid Nanoparticles for Gene TherapyKelly Godbout, Jacques P Tremblay
Medecine Sciences : M/S|October 25, 2024
[Correcting pathogenic mutations using prime editing: an overview]Camille Bouchard, Kelly Godbout, Jacques P Tremblay
Cells|January 11, 2024
Successful Correction by Prime Editing of a Mutation in the <i>RYR1</i> Gene Responsible for a MyopathyKelly Godbout, Joël Rousseau, Jacques P Tremblay
Molecular Therapy. Nucleic Acids|October 16, 2023
CRISPR-Cas9 delivery strategies with engineered extracellular vesiclesYaoyao Lu, Kelly Godbout, Gabriel Lamothe, et al.
International Journal of Molecular Sciences|April 17, 2025
Universal Prime Editing Therapeutic Strategy for RyR1-Related Myopathies: A Protective Mutation Rescues Leaky RyR1 ChannelKelly Godbout, Mathieu Dugas, Steven R Reiken, et al.
The Journal of Clinical Investigation|February 4, 2025
Sleep-wake variation in body temperature regulates tau secretion and correlates with CSF and plasma tauGeoffrey Canet, Felipe Da Gama Monteiro, Emma Rocaboy, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Cells|February 25, 2023
Prime Editing for Human Gene Therapy: Where Are We Now?Kelly Godbout, Jacques P Tremblay
Pharmaceutics|October 27, 2022
Delivery of RNAs to Specific Organs by Lipid Nanoparticles for Gene TherapyKelly Godbout, Jacques P Tremblay
Medecine Sciences : M/S|October 25, 2024
[Correcting pathogenic mutations using prime editing: an overview]Camille Bouchard, Kelly Godbout, Jacques P Tremblay
Cells|January 11, 2024
Successful Correction by Prime Editing of a Mutation in the <i>RYR1</i> Gene Responsible for a MyopathyKelly Godbout, Joël Rousseau, Jacques P Tremblay
Molecular Therapy. Nucleic Acids|October 16, 2023
CRISPR-Cas9 delivery strategies with engineered extracellular vesiclesYaoyao Lu, Kelly Godbout, Gabriel Lamothe, et al.
International Journal of Molecular Sciences|April 17, 2025
Universal Prime Editing Therapeutic Strategy for RyR1-Related Myopathies: A Protective Mutation Rescues Leaky RyR1 ChannelKelly Godbout, Mathieu Dugas, Steven R Reiken, et al.
The Journal of Clinical Investigation|February 4, 2025
Sleep-wake variation in body temperature regulates tau secretion and correlates with CSF and plasma tauGeoffrey Canet, Felipe Da Gama Monteiro, Emma Rocaboy, et al.
Pageof 1